Assignee
CELTRIX PHARMA
US·46 granted patents·2 pending applications·2,320 citations·filing 1991–2001
Top patents by PatentIndex Score
48 records- 0195US5824467AMethods for predicting drug responseCELTRIX PHARMA·Filed 1997·Granted Oct 20, 1998·155 cites·6 claims
- 0295US5571714AMonoclonal antibodies which bind both transforming growth factors β1 and β2 and methods of useCELTRIX PHARMA·Filed 1991·Granted Nov 5, 1996·197 cites·9 claims
- 0395US5118667ABone growth factors and inhibitors of bone resorption for promoting bone formationCELTRIX PHARMA·Filed 1991·Granted Jun 2, 1992·340 cites·68 claims
- 0494US5393739AUse of bone morphogenetic protein in synergistic combination with TGF-β for bone repairCELTRIX PHARMA·Filed 1993·Granted Feb 28, 1995·150 cites·4 claims
- 0590US5914254AExpression of fusion polypeptides transported out of the cytoplasm without leader sequencesCELTRIX PHARMA·Filed 1997·Granted Jun 22, 1999·118 cites·29 claims
- 0690US5772998AMonoclonal antibodies to transforming growth factor-beta and methods of useCELTRIX PHARMA·Filed 1995·Granted Jun 30, 1998·59 cites·7 claims
- 0790US5767079AMethod of treating ophthalmic disorders using TGF -βCELTRIX PHARMA·Filed 1996·Granted Jun 16, 1998·147 cites·48 claims
- 0889US6087090AMethods for predicting drug responseCELTRIX PHARMA·Filed 1998·Granted Jul 11, 2000·89 cites·19 claims
- 0985US5563046AFusion polypeptides and proteinsCELTRIX PHARMA·Filed 1993·Granted Oct 8, 1996·52 cites·25 claims
- 1085US5470727AChromosomal expression of non-bacterial genes in bacterial cellsCELTRIX PHARMA·Filed 1993·Granted Nov 28, 1995·69 cites·1 claims
- 1184US5783185AMonoclonal antibodies to transforming growth factor-beta and methods of useCELTRIX PHARMA·Filed 1995·Granted Jul 21, 1998·49 cites·7 claims
- 1283US5420243ABiologically active TGF-β2 peptidesCELTRIX PHARMA·Filed 1993·Granted May 30, 1995·42 cites·11 claims
- 1382US5208219AMethod for inducing bone growthCELTRIX PHARMA·Filed 1991·Granted May 4, 1993·107 cites·31 claims
- 1481US5723441AMethod of treating renal disease by administering IGF-I and IGFBP-3CELTRIX PHARMA·Filed 1995·Granted Mar 3, 1998·70 cites·18 claims
- 1578US6040292AMethods for treating diabetesCELTRIX PHARMA·Filed 1999·Granted Mar 21, 2000·43 cites·14 claims
- 1678US6015786AMethod for increasing sex steroid levels using IGF or IGF/IGFBP-3CELTRIX PHARMA·Filed 1997·Granted Jan 18, 2000·33 cites·6 claims
- 1775US5830706APolypeptide fusions to polypeptides of the beta-trefoil fold structural familyCELTRIX PHARMA·Filed 1995·Granted Nov 3, 1998·21 cites·16 claims
- 1875US5681818ATherapeutic uses of human somatomedin carrier proteinsCELTRIX PHARMA·Filed 1994·Granted Oct 28, 1997·31 cites·16 claims
- 1975US5407913AMethod and composition for systemic treatment of tissue injuryCELTRIX PHARMA·Filed 1992·Granted Apr 18, 1995·50 cites·28 claims
- 2074US6417330B1Insulin-like growth factor binding protein variantsCELTRIX PHARMA·Filed 1999·Granted Jul 9, 2002·22 cites·8 claims
- 2174US5914390AMethods for increasing yields of recombinant proteinsCELTRIX PHARMA·Filed 1997·Granted Jun 22, 1999·28 cites·50 claims
- 2272US6436897B2Pharmaceutical formulations for IGF/IGFBPCELTRIX PHARMA·Filed 1998·Granted Aug 20, 2002·30 cites·25 claims
- 2372US5462925ATransforming growth factor β2,3CELTRIX PHARMA·Filed 1992·Granted Oct 31, 1995·26 cites·2 claims
- 2469US5413989AMethod and activin compositions for inducing bone growthCELTRIX PHARMA·Filed 1993·Granted May 9, 1995·59 cites·15 claims
- 2569US5200509AHuman somatomedin carrier protein subunits and process for producing them; recombinant DNA molecules, hosts, processes and human somatomedin carrier protein-like polypeptidesCELTRIX PHARMA·Filed 1991·Granted Apr 6, 1993·28 cites·1 claims
- 2668US6514937B1Method of treating psychological and metabolic disorders using IGF or IGF/IGFBP-3CELTRIX PHARMA·Filed 1998·Granted Feb 4, 2003·24 cites·1 claims
- 2768US5629172AExpression of fusion polypeptides transported out of the cytoplasm without leader sequencesCELTRIX PHARMA·Filed 1994·Granted May 13, 1997·20 cites·23 claims
- 2866US6025368AMethod for treating the symptoms of chronic stress-related disorders using IGFCELTRIX PHARMA·Filed 1997·Granted Feb 15, 2000·29 cites·6 claims
- 2966US6025332AMethod for treating low circulating levels of sex hormone steroids associated with aging using IGF or IGF/IGFBP-3CELTRIX PHARMA·Filed 1998·Granted Feb 15, 2000·16 cites·3 claims
- 3066US5426098AIncrease in hematopoietic progenitor cells in peripheral blood by transforming growth factor betaCELTRIX PHARMA·Filed 1993·Granted Jun 20, 1995·29 cites·5 claims
- 3165US5624805AUses for antibodies which bind to human somatomedin carrier protein subunitsCELTRIX PHARMA·Filed 1995·Granted Apr 29, 1997·12 cites·2 claims
- 3262US5527776ATreatment of immunologic and hematologic disorders with IGFBP alone or complexed with IGFCELTRIX PHARMA·Filed 1995·Granted Jun 18, 1996·22 cites·1 claims
- 3361US6124259AMethod for treating ophthalmic disorders with IGFBPCELTRIX PHARMA·Filed 1998·Granted Sep 26, 2000·29 cites·14 claims
- 3457US5670341ADNA vectors, hosts, probes and recombinant methods of preparing human somatomedin-like carrier proteins or polypeptidesCELTRIX PHARMA·Filed 1995·Granted Sep 23, 1997·14 cites·20 claims
- 3557US5658883ABiologically active TGF-β1 peptidesCELTRIX PHARMA·Filed 1995·Granted Aug 19, 1997·11 cites·14 claims
- 3656US5643867AMethod for treating catabolic conditionsCELTRIX PHARMA·Filed 1995·Granted Jul 1, 1997·19 cites·22 claims
- 3755US2001034433A1Human somatomed in carrier protein subunits and process for producing them; recombinant DNA molecules, hosts, processes and human somatomedin carrier protein-like polypeptidesCELTRIX PHARMA·Filed 2001·Application pending·0 cites
- 3853US5650396AMethods of modulating inflammatory cytokines in the CNS using TGF-βCELTRIX PHARMA·Filed 1994·Granted Jul 22, 1997·22 cites·3 claims
- 3953US5459051AMethods and vectors for over-expression of ubiquitin fusion proteins in host cellsCELTRIX PHARMA·Filed 1993·Granted Oct 17, 1995·12 cites·18 claims
- 4051US5674843AIncrease in hematopoietic progenitor cells in peripheral blood by transforming growth factor βCELTRIX PHARMA·Filed 1995·Granted Oct 7, 1997·9 cites·4 claims
- 4151US2002072589A1Insulin-like growth factor binding protein variantsCELTRIX PHARMA·Filed 2001·Application pending·0 cites
- 4249US6017885AIGF/IGFBP complex for promoting bone formation and for regulating bone remodelingCELTRIX PHARMA·Filed 1998·Granted Jan 25, 2000·11 cites·8 claims
- 4346US6518238B1Method of treating psychological and metabolic disorders using IGF or IGF/IGFBP-3CELTRIX PHARMA·Filed 1999·Granted Feb 11, 2003·4 cites·4 claims
- 4446US5789547AMethod of producing insulin-like growth factor-I (IGF-I) and insulin-like growth factor binding protein-3 (IGFBP-3) with correct folding and disulfide bondingCELTRIX PHARMA·Filed 1995·Granted Aug 4, 1998·6 cites·34 claims
- 4546USRE35694EPolypeptide cartilage-inducing factors found in boneCELTRIX PHARMA·Filed 1994·Granted Dec 16, 1997·8 cites·1 claims
- 4643US5948757AHigh dose IGF-1 therapyCELTRIX PHARMA·Filed 1996·Granted Sep 7, 1999·8 cites·2 claims
- 4732US7288516B1Null IGF for the treatment of cancerCELTRIX PHARMA·Filed 1999·Granted Oct 30, 2007·0 cites·39 claims
- 4824US5529982AInducing granulocyte production or B cell production in peripheral blood by TGF-βCELTRIX PHARMA·Filed 1994·Granted Jun 25, 1996·0 cites·3 claims
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →